Cardiology Perspective

 
 
  • 'Difficult Patient': Stigmatizing Words and Medical Error   In a hospital study, the use of certain words and language patterns in the medical record was linked with diagnostic errors. Dr F Perry Wilson comments.
  • A Shot in the Arm for Uncontrolled Hypertension   Cardiologists Michelle O'Donoghue and Akshay Desai discuss the results of KARDIA-2 on the siRNA drug zilebesiran in patients with uncontrolled hypertension and the potential role of renal denervation.
  • ACC 2024: Insights on Advancements in Lipid Management   Dr Erin D. Michos highlights five trials presented at ACC that offer exciting advancements in lipid science.
  • Apr 12 2024 This Week in Cardiology   ACC Recap #1: DanGer Shock (plus a sobering JAMA research letter on Impella use), REDUCE-AMI, PREVENT, and EMPACT-MI are the topics John Mandrola, MD, covers in this week’s podcast.
  • EMPACT-MI: Another SGLT2 Inhibitor Miss Post-MI Empagliflozin added to standard care did not improve outcomes in post-MI patients at risk for heart failure. John Mandrola, MD, sees the diminishing returns for add-on drugs as positive for patients.
  • Identification and Management of MASLD: Primary Care Tips   Dr Kevin Fernando discusses the identification and management of people with MASLD in primary care.
  • Is Your EMS System Leading the Way in Emergency Care?   Join Drs Glatter and Pepe as they explore the intricacies of EMS care, revealing disparities and providing insights and solutions alongside Dr Weston.
  • Managing CKD in Primary Care: Latest Guidelines   An explosion of new treatments can stave off the need for dialysis in many patients with CKD.
  • ACC 2024 Beta-Blockers Post-MI Past Their Expiration Date: REDUCE-AMI REDUCE-AMI showed no benefit for routine beta-blockers post–MI in patients with normal ejection fraction. John Mandrola, MD, asks: Does evidence-based medicine need expiration dates?
  • ACC 2024 Impella Saves Lives in CS, but Patient Selection Key In the first randomized trial of Impella in a select group of patients with AMI and cardiogenic shock, the device saved lives. The high rate of serious adverse events calls us to pay attention to the nuances of the data, says John Mandrola, MD.
  • Apr 05 2024 This Week in Cardiology   Statins and diabetes, AAD in patients with heart disease, tricuspid valve interventions, and an ACC preview are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Mandrola's Three Trials to Look For at the 2024 ACC Trials on chelation therapy, the Impella device, and beta-blockers are cardiologist John Mandrola's picks for the upcoming American College of Cardiology Meeting in Atlanta.
  • A Banned Chemical That Is Still Causing Cancer   This is one time when being at the top of the food chain is not advantageous.
  • Conference MDAngle: ACC 2024 Atherosclerosis and Lipid Management   Dr Erin D. Michos provides highlights from ACC 2024, including anticipated presentations, quick takeaways, and insights into how the presented research will impact patients.
  • ACC 2024: Anticipating Advancements in Lipid Management   Dr Erin D. Michos previews four late-breaking trials to be presented at ACC on novel therapies for lipid management.
  • Mar 29 2024 This Week in Cardiology   Intermittent fasting, anticoagulation decisions, heterogenous treatment effects, frailty in HF, the importance of the ECG, and industry conflicts are the topics John Mandrola, MD, covers this week.
  • Medscape Cardiologist Burnout & Depression Report 2024 Cardiologists experiencing burnout or depression reveal how long they've felt that way, what they do to feel better, and their comfort with confiding in mental health professional or colleagues.
  • No, Intermittent Fasting Won't Kill You Cardiologist and epidemiologist Chris Labos debunks the headline-grabbing intermittent fasting study that claimed the dietary habit nearly doubled the risk of dying from cardiovascular disease.
  • The Truth About Compounded GLP-1s That Doctors Need to Know Medical societies and the FDA have issued critiques about compounding pharmacies, but Eldad Einav, MD, argues that there are steps that can be taken to ensure patient safety.
  • Infographic: Where Volunteer Doctors Are Most Needed Several of the volunteer organizations that need help from physicians to treat and train -- from the American Red Cross to Doctors Without Borders -- are spotlighted.
  • AHA 2021 AHA 2021
  • BCS 2021 BCS 2021
  • ESC 2021 ESC 2021 Read clinically focused news coverage of key developments from ESC 2021
  • TCT 2020 TCT 2020
  • ESC 2020 ESC 2020